J. C. Sammartino

Engineered dimeric and secretory IgA1 neutralized Omicron variants with higher potency than parental IgG.

This study evaluates a tetravalent SARS-CoV-2 S1 subunit vaccine in SIV-infected rhesus macaques, showing robust humoral and cellular immune responses, including cross-reactivity against Omicron.

This study shows that a S1 subunit booster vaccine enhances neutralizing antibodies and cross-reactivity against multiple SARS-CoV-2 variants in aged mice vaccinated with an adenovirus-based vaccine.

This study tracks SARS-CoV-2 immunity in patients up to 15 months post-infection, showing sustained antibody and memory B/T cell responses but reduced neutralization against variants.

This study identifies selamectin as an inhibitor of the mycobacterial DprE1 enzyme, showing susceptibility in mutants and docking predictions, but with conflicting results in phenotypic assays and metabolic labeling.